Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

MediPharm Labs Q2 EPS $(0.01) Up From $(0.01) YoY, Sales $11.808M Beat $11.006M Estimate

Author: Benzinga Newsdesk | August 14, 2025 06:58am
MediPharm Labs (TSX:LABS) reported quarterly losses of $(0.01) per share. This is a 10 percent increase over losses of $(0.01) per share from the same period last year. The company reported quarterly sales of $11.808 million which beat the analyst consensus estimate of $11.006 million by 7.29 percent. This is a 14.09 percent increase over sales of $10.350 million the same period last year.

Posted In: TSX:LABS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist